Christine T. De Lara
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort☆.
Journal: ESMO open
Published: February 26, 2021
Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions.
Journal: Annals of surgical oncology
Published: April 28, 2020
Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients.
Journal: Clinical breast cancer
Published: May 12, 2019
Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials.
Journal: British journal of cancer
Published: March 25, 2019
Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact.
Journal: Breast cancer research and treatment
Published: August 21, 2018
Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
Journal: Breast cancer research and treatment
Published: July 05, 2018
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit.
Journal: Breast cancer research and treatment
Published: June 11, 2018
Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survival.
Journal: BMC surgery
Published: July 23, 2016
Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.
Journal: British journal of cancer
Published: June 05, 2015
Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 18, 2013
Neoadjuvant endocrine treatment in breast cancer: analysis of daily practice in large cancer center to facilitate decision making.
Journal: American journal of surgery
Published: February 15, 2013
Last Updated: 09/26/2026